Scynexis (SCYX) Interest Coverage Ratio Growth (3y) (2016 - 2025)
Powered by 
Analysis
Scynexis (SCYX) Interest Coverage Ratio Growth (3y) (2016 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 13.52% |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -98.43% |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 29.79% |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 44.22% |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 33.30% |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Scynexis | 58.41 Mn | -56.29 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -38.73% |
| Dec 31, 2024 | -18.90% |
| Sep 30, 2024 | -36.43% |
| Jun 30, 2024 | -6.02% |
| Mar 31, 2024 | -83.97% |
| Dec 31, 2023 | -29.69% |
| Sep 30, 2023 | -10.94% |
| Jun 30, 2023 | 88.98% |
| Mar 31, 2023 | 50.10% |
| Dec 31, 2022 | 39.54% |
| Sep 30, 2022 | 35.13% |
| Jun 30, 2022 | 30.92% |
| Mar 31, 2022 | 16.76% |
| Dec 31, 2021 | -2.34% |
| Sep 30, 2021 | -9.61% |
| Jun 30, 2021 | -26.82% |
| Mar 31, 2021 | 26.92% |
| Dec 31, 2020 | -35.50% |
| Sep 30, 2020 | -26.69% |
| Jun 30, 2020 | -1.59% |